KCl-retard Hausmann

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of KCl-retard Hausmann

Quick Facts

Property Description
Active Ingredient Potassium Chloride (KCl)
Form Slow-release tablet (Retard film-coated)
Pharmacological Class Electrolyte substitute / Potassium supplement
Common Use Restoring Potassium deficiency (Hypokalemia)
Origin Synthetic chemical compound

What Type of Medicine is KCl-retard Hausmann?

KCl-retard Hausmann is a prescription-only pharmacological agent that belongs to the class of electrolyte substitutes and functions specifically as a potassium supplement. The medicine's core is the delivery of the essential active ingredient, Potassium Chloride (KCl), when the body is confirmed to have a deficiency. Potassium Chloride serves as the agent used to treat and prevent states of potassium depletion. This establishes the medicine as a targeted therapy for correcting a vital mineral imbalance, which is clinically recognized for stabilizing the body's electrical functions.

The product is a single-ingredient product, focusing exclusively on potassium replenishment. It is often used in scenarios where a patient's diet or certain medications have led to a medically recognized loss of potassium, serving as a direct and well-established means of restoring balance.


Composition and the Slow-Release Form (Retard)

The active substance in this medication is the synthetic compound Potassium Chloride, which is formulated into a specialized slow-release tablet known as a retard film-coated tablet. This oral dosage form ensures that the Potassium Chloride is released gradually into the digestive system.

The significance of the term Retard is that the active ingredient is embedded within a unique slow-release matrix to achieve controlled dispersal, rather than releasing the entire dose immediately. Such modified-release formulations are used for active substances, like concentrated salts, to improve patient tolerability and reduce local gastrointestinal irritation. This controlled-release technology is a differentiating factor because it promotes steady, continuous absorption of the potassium into the body over several hours.


General Purpose and Physiological Role

The general purpose of KCl-retard Hausmann is to safely and effectively provide potassium ions to counteract a state of potassium deficiency (hypokalemia). By restoring these vital mineral levels, the medicine helps to regulate critical bodily functions dependent on balanced electrolytes.

Potassium is essential for maintaining the communication system of the body, specifically supporting the proper transmission of nerve signals and the necessary contraction of all muscle groups, including the heart. The overall benefit is the restoration of these fundamental processes to ensure optimal function of the entire neuromuscular system.

Advertisements

What side effects are possible with KCl-retard Hausmann?

Possible Side Effects and Safety Information

Key Safety Concerns

The most significant systemic risk associated with potassium chloride supplements is Hyperkalemia (excessive potassium in the blood), which can be severe and potentially life-threatening, leading to cardiac and neuromuscular disturbances. Serious complications of overdose include severe hypotension, shock, and cardiac arrest.

The prolonged-release nature of the tablet also carries a risk of serious, localized Gastrointestinal Ulceration, Hemorrhage, or Obstruction.

Documented Adverse Reactions

Adverse effects are categorized by frequency based on regulatory documentation:

Frequency System-Organ Class Specific Adverse Reactions
Rare (1/10,000 to 1/1,000) Gastrointestinal, Skin and Subcutaneous Tissue Gastrointestinal irritation, vomiting, diarrhea, abdominal pain, flatulence, pruritus (itching), skin rash, and urticaria (hives).
Very Rare (<1/10,000) Gastrointestinal Obstruction, hemorrhage, and ulceration (with or without perforation) of the upper or lower gastrointestinal tract.
Not Known Metabolism and Nutrition Hyperkalemia (frequency varies with underlying conditions and dose).

Contraindications and Limitations

KCl-retard Hausmann is strictly contraindicated in patients with:

  • Existing Hyperkalemia.
  • Renal insufficiency or severely reduced urine output (oliguria).
  • Untreated adrenal gland insufficiency (e.g., Addison's disease).
  • Severe dehydration (exsiccosis) or severe burns.
  • Existing gastrointestinal ulcers, stenosis (narrowing), or atonia (lack of tone) of the gastrointestinal tract.
  • Concomitant use with potassium-sparing diuretics (spironolactone, triamterene, amiloride) or anticholinergics.

Special caution is required for patients with cardiovascular diseases, renal diseases (to ensure proper potassium elimination), and congenital myotonia (Thomsen's disease).

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose of potassium chloride, primarily due to an excess of potassium, leads to a condition called hyperkalemia (high potassium level in the blood). This condition is considered dangerous, with a significant risk of severe and potentially fatal cardiac disorders.

Documented Overdose Symptoms

The physiological systems most affected are the cardiovascular, neuromuscular, and gastrointestinal systems. Key clinical manifestations of overdose include electrocardiographic changes such as peaked T-waves and a widening QRS complex, leading to bradycardia (slow heart rate), AV block, and potentially ventricular fibrillation or diastolic cardiac arrest.

Neuromuscular symptoms like general muscle weakness or ascending paralysis may also occur. Gastrointestinal symptoms, such as severe stomach pain, vomiting, or bloody/black stools, are also noted.

Factors and Emergency Response

The risk of severe hyperkalemia is particularly high in patients with renal insufficiency or acidosis. Furthermore, administering the total daily dose as a single application is explicitly unsuitable as it can provoke an overdose.

Immediate medical attention is required if a patient experiences severe symptoms, or if the stool becomes bloody or black. In cases of overdose, treatment focuses on removing excess potassium and stabilizing the heart. Emergency actions may include infusions of ion exchangers or, in severe, life-threatening cases, rapid hemodialysis, which may be necessary and life-saving.

Advertisements

Therapeutic Uses of KCl-retard Hausmann

What KCl-retard Hausmann Treats: Main Uses and Benefits

KCl-retard Hausmann is used to address hypokalemia, a condition characterized by a systemic imbalance due to low potassium levels in the blood. It is utilized when supportive management is appropriate, helping to maintain electrolyte stability. The core therapeutic focus is the treatment and prevention of this deficiency.


The medication is relevant for easing groups of symptoms that may appear suddenly or intensify over time, providing support that helps manage the overall burden of the condition. Its application is relevant for issues presenting with systemic imbalance, muscular discomfort, and organ-specific functional stress. It is often used during phases when symptoms become more noticeable, helping patients cope more steadily with difficult episodes and symptom fluctuations.

Quick Fact: Functional Support for Muscular Symptoms

This medication is relevant for easing symptoms of increased neurological or muscular activity that interfere with daily functioning, such as weakness or cramping, which are common manifestations of the underlying potassium deficiency.

Regulatory References

  1. NIH DailyMed Prescribing Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use KCl-retard Hausmann?

Eligibility to use KCl-retard Hausmann is strictly defined by regulatory documents based on a patient’s potassium status and physiological health, primarily to prevent hyperkalemia (excessive potassium in the blood) and gastrointestinal injury.

Absolute Contraindications

This medicine is contraindicated and must not be used in patients with the following conditions, as stated in the prescribing information:

  • Hyperkalemia or conditions predisposing to it, such as severe renal impairment.
  • Gastrointestinal ulcers or any condition causing obstruction or severely delayed transit (specific to the slow-release tablet form).
  • Untreated adrenocortical insufficiency or concurrent use of potassium-sparing diuretics.

Age and Condition Restrictions

Population Regulatory Status
Pediatric Use (Extended-Release) Safety and effectiveness of the extended-release tablet formulation are not established in children.
Older Adults (65+) Use requires caution; dosing should start at the low end of the range due to the higher frequency of reduced organ function.
Renal/Hepatic Impairment Requires frequent monitoring and careful dose selection, unless the impairment is severe, in which case the medicine is contraindicated.
Pregnancy/Lactation Not expected to cause harm if supplementation does not lead to hyperkalemia.
Advertisements

What should I know about interactions with other medicines?

KCl-retard Hausmann Interactions with other medicines and products

Interactions with Potassium Chloride, the active ingredient in KCl-retard Hausmann, are officially documented to occur primarily through two mechanisms: increased systemic potassium concentration and localized gastrointestinal effects due to the slow-release formulation.

The most significant interaction involves a pharmacodynamic effect that increases the risk of severe hyperkalemia (excessive blood potassium levels). This occurs when the medicine is combined with agents that reduce potassium excretion.

Interaction-Related Restrictions

Classification Interacting Agents Official Interaction Outcome
Contraindicated Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene) Prohibited due to severe, life-threatening hyperkalemia risk.
Significant Risk ACE inhibitors, ARBs, Renin Inhibitors, Heparin, Immunosuppressants (Cyclosporine, Tacrolimus) Officially documented to increase the risk of hyperkalemia.

Formulation and Conditional Interactions

The slow-release solid oral formulation can lead to a specific exposure interaction. Medications that significantly slow gastrointestinal (GI) motility, such as anticholinergic agents, may prolong the contact time of the tablet with the GI lining. This prolonged local exposure may increase the risk of serious gastrointestinal lesions.

Furthermore, all interactions that increase serum potassium are noted in regulatory labels to be significantly heightened in patients with impaired renal function. The restriction on combining the product with potassium-containing salt substitutes is also documented due to the additive potassium load.

Advertisements

Mechanism of Action

The mechanism acts within the domain of ion and electrolyte balance by directly supplying the essential potassium ion ( K^+). This substitution supports the ubiquitous Na^+/ K^+-ATPase pump in correcting the concentration ratio across the cell membrane. This engagement of primary ion transporters modifies the cell’s electrical state, reversing hyperpolarization and establishing the correct Resting Membrane Potential that supports cellular excitability.

By normalizing the membrane potential, the drug modulates key pathways associated with action potential dynamics in excitable tissues. This corrected electrical balance influences the function of specialized K^+-selective ion channels, leading to the modulation of the Cardiac Electrophysiological Pathway (myocardial rhythmicity) and influencing Neuromuscular Excitability. This mechanism modifies the fundamental electrical signals that influence cardiac electrophysiology and muscle contraction.

The use of a prolonged-release (Retard) matrix engages a critical mechanistic pattern of sustained modulation. This formulation ensures the K^+ ion is introduced gradually and continuously over several hours. This prevents the functional consequence of high local concentrations—a mechanism that facilitates the integration of the K^+ load by homeostatic regulators, such as the kidneys, and extends the resulting physiological adjustment.

Advertisements

Dosage and Administration Information

How to Use KCl-retard Hausmann — Administration Guidelines

KCl-retard Hausmann is administered exclusively via the oral route as a slow-release, film-coated tablet. This extended-release design is crucial as it ensures the potassium chloride is dispersed gradually to aid in steady absorption. Due to this specialized formulation, the tablets must be swallowed whole without crushing, chewing, or sucking, which is a core procedural instruction for this dosage form.


Standard Dosing and Administration Conditions

Daily dosing must be guided by laboratory results, specifically the patient’s serum potassium concentration. For treatment of established deficiency, the typical adult dose ranges from 40 to 100 mEq per day. For maintenance or prophylaxis, a lower dose of 20 to 50 mEq per day is common.

If the total daily dosage exceeds 20 mEq, it is standard practice to administer the amount in two or more divided doses throughout the day. The maximum single oral dose is typically limited to 20 mEq of potassium.


Required Timing and Adjustments

Administration Rule Procedural Requirement Basis for Requirement
Timing in Relation to Meals Must be taken with a meal or immediately following food intake and with a full glass of liquid. Minimizes potential for gastrointestinal irritation
Population Cautions Initiation of therapy in older adults or those with renal impairment should begin at the low end of the dosing range. Acknowledges potential for reduced elimination in these groups
Therapy Duration Therapy can be short-term or long-term; duration and dose adjustment are determined by periodic monitoring of serum potassium levels. Necessary for titrating the dose to the clinical deficit

This protocol establishes a standardized, laboratory-guided framework for the use of the medicine, ensuring its slow-release properties are preserved during oral delivery.

Advertisements

Recent Clinical Evidence

Clinical Evidence Overview

KCl-retard Hausmann is an oral, extended-release formulation of Potassium Chloride (KCl), intended to replenish potassium stores in the body and treat or prevent hypokalemia (low blood potassium) that may be associated with conditions like metabolic alkalosis or certain diuretic therapies.

Efficacy and Indication

Clinical data consistently support the use of oral potassium chloride for managing potassium depletion. Extended-release formulations, like KCl-retard Hausmann, are primarily developed to provide a sustained release of potassium ions, which contributes to maintaining stable serum potassium levels over a longer period.

  • Target Condition: The drug is indicated for the treatment of hypokalemia, particularly in patients for whom dietary management or reduction of diuretic dosage is insufficient.
  • Clinical Goal: The objective in clinical practice is to raise and stabilize the potassium concentration in the plasma, which is generally maintained within a narrow range (e.g., 3.5–5.0 mmol/L in healthy adults).

Formulations and Safety Profile

Controlled-release oral potassium preparations were developed specifically to reduce the risk of high localized potassium concentration in the gastrointestinal (GI) tract. This high concentration, associated with immediate-release salts, had been linked to a greater risk of local tissue damage, including ulceration and bleeding.

Feature Clinical Benefit
Extended Release Slow, uniform release to minimize peak concentration in the GI mucosa.
Matrix Structure The insoluble matrix of the tablet is eliminated in the stool after the active substance is released, ensuring controlled delivery.

Observed side effects commonly relate to the GI tract, including nausea, vomiting, abdominal discomfort, and flatulence. Serious adverse effects, such as GI obstruction or perforation, are rare but remain a known risk associated with all solid oral potassium chloride products, particularly if GI transit is impaired.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about KCl-retard Hausmann (FAQ)


Q: How quickly should I expect to see an effect after starting KCl-retard Hausmann?

A: Studies on slow-release potassium formulations indicate that peak serum potassium levels in the bloodstream generally occur about mathbf4 hours after the tablet is taken. This timing reflects the mathbfcontrolled-release design of the tablet, which is engineered for sustained absorption.

Q: Does KCl-retard Hausmann interact with common pain relievers like ibuprofen?

A: Yes, official drug information documents state that mathbfNonsteroidal Anti-Inflammatory Drugs (NSAIDs), a class that includes ibuprofen, may mathbfincrease the risk of hyperkalemia (excessive blood potassium levels) when taken with this medication. Regulatory warnings indicate that this risk must be considered during treatment.

Q: What are the signs that my potassium levels might be getting too high while on this drug?

A: Signs of very high potassium, known as mathbfhyperkalemia, are described in regulatory documents. These can include mathbfmuscle weakness, mathbftingling or numbness, mathbfunusual tiredness, a mathbfslow or irregular heartbeat, and mathbfconfusion. If symptoms of hyperkalemia are noticed, it is described as a condition requiring mathbfurgent medical assessment.

Q: Does KCl-retard Hausmann make you feel tired or dizzy?

A: Regulatory documents do not list fatigue or dizziness as typical side effects at normal therapeutic doses. However, mathbfdizziness and mathbfunusual tiredness or weakness are noted as possible symptoms of mathbfhyperkalemia (dangerously high potassium levels), which is noted as a serious potential risk when using potassium supplements.

Q: Are there any known interactions with herbal supplements?

A: Official information provides a general warning against using mathbfcertain nutritional supplements alongside this medication due to the potential risk of increasing potassium levels in the blood ( hyperkalemia). Official documentation notes that all products, including supplements, are factored into treatment decisions.

Q: Do researchers know if KCl-retard Hausmann is better absorbed than liquid potassium?

A: Studies indicate that the overall bioavailability—meaning the amount of potassium that is absorbed into the body from the tablet—is generally mathbfcomparable to that of liquid potassium solutions when measured over a 24-hour period.

Q: Are mental side effects, like confusion, associated with this medication?

A: The official product information mentions mathbfconfusion as a potential symptom of a medical emergency called mathbfhyperkalemia, which is dangerously high potassium in the blood. Confusion is not listed as a common side effect when the medicine is used correctly.

Q: What is the physical appearance of the KCl-retard Hausmann tablet?

A: According to official descriptions, this product is supplied as a mathbffilm-coated extended-release tablet. The specific color or unique markings can vary based on the manufacturer and the strength of the tablet.

Q: Is this medicine only for people with severe potassium deficiency?

A: No. The medication is officially indicated for the mathbftreatment of existing low potassium ( hypokalemia) as well as for the mathbfprophylaxis (prevention) of low potassium. It is used when changes in diet or reduction of other medications, such as diuretics, are insufficient.

Q: What is the difference between KCl-retard Hausmann and other potassium supplements I see in stores?

A: The Retard formulation is an mathbfextended-release oral tablet, a feature highlighted in official documents as a mathbfdifferentiating factor. This specialized design allows the potassium to be released mathbfgradually over several hours, which helps reduce the risk of irritation to the stomach and intestines.

Q: Is it safe to take KCl-retard Hausmann if I also take a blood pressure medication?

A: Regulatory warnings specifically address the combination of this product with certain blood pressure medicines. Official documentation highlights that mathbfACE inhibitors, mathbfARBs, and mathbfRenin Inhibitors increase the risk of mathbfhyperkalemia (high potassium). The potential for hyperkalemia is why this combination is a mathbffactor in treatment planning.

Q: Are there any foods or drinks I should avoid while taking this medicine?

A: Yes. Official drug labels specifically advise against the use of mathbfpotassium-containing salt substitutes. Official documents also advise against the use of mathbfother supplements that contain potassium to prevent an excessive potassium load.

Q: Can KCl-retard Hausmann affect my kidney function?

A: The medication is mathbfcontraindicated (must not be used) in patients with mathbfsevere renal impairment. This restriction is because existing kidney issues reduce the body's ability to eliminate potassium, which significantly increases the risk of mathbfhyperkalemia (dangerously high potassium). This medication is contraindicated when severe kidney function issues exist, which limits the body's ability to process potassium.

Q: Is it possible to be allergic to KCl-retard Hausmann?

A: While severe, specific allergy is rare, official documents do list mathbfskin rash and mathbfurticaria (hives) as potential side effects. These can be signs of a mathbfhypersensitivity reaction. If symptoms of a hypersensitivity reaction are noticed, official safety information indicates the need for mathbfmedical assessment.

Q: If I have mild symptoms of low potassium, is this the right medication?

A: Official guidelines indicate that this medication is used when mathbfdietary management with potassium-rich foods mathbfis insufficient to correct the low potassium level. Mild cases may first be addressed through diet. The determination to use this product is based on an mathbfofficial clinical assessment.

Q: What happens if I accidentally take more than the amount my doctor suggested?

A: Taking too much can result in mathbfsevere hyperkalemia (excessive blood potassium), which is a serious medical event. Regulatory documents warn that this can lead to mathbfcardiac arrhythmias, mathbfcardiac arrest, and mathbfshock. If an overdose is suspected, official warnings indicate this is a situation mathbfrequiring urgent medical assessment.

Q: What specific conditions must be checked before a doctor prescribes this?

A: Official documents require that the doctor monitor the serum potassium concentration (via a blood test) both before starting therapy and periodically while taking the medication. mathbfRenal (kidney) function is also a key factor that must be assessed, as severe impairment is a contraindication.

Q: Is KCl-retard Hausmann used for conditions other than low blood potassium?

A: Yes. While the primary use is to correct low blood potassium ( hypokalemia), some official product labels state that potassium chloride may also be used in the treatment of mathbfdigitalis intoxication and to manage patients with mathbfhypokalemic familial periodic paralysis.

Q: How does the body normally get rid of excess potassium?

A: Potassium balance in the body is maintained primarily by the mathbfkidneys. Official documents note that approximately mathbf90% of the potassium consumed daily is mathbfexcreted in the urine by this mechanism.

Q: What evidence is available regarding its use in people with heart conditions?

A: Regulatory documents carry mathbfwarnings for the use of potassium supplements in patients with pre-existing mathbfcardiovascular diseases. This is due to the risk that mathbfhyperkalemia (high potassium) can cause mathbfsevere cardiac disturbances such as arrhythmias and cardiac arrest, and this risk is a mathbffactor in treatment planning for patients with heart conditions.

Q: Can I take this medication if I have difficulty swallowing?

A: Official guidance states that the extended-release tablet mathbfmust be swallowed whole to maintain its slow-release properties. Patients who have mathbfdysphagia (trouble swallowing) or severe gastrointestinal movement issues are advised to mathbfconsider the use of liquid potassium formulations instead.

Q: Is the potassium in KCl-retard Hausmann the same as the potassium found in bananas?

A: The medicine contains the synthetic compound mathbfPotassium Chloride (KCl). The potassium found naturally in foods like bananas typically exists as mathbfother potassium salts such as potassium citrate or malate.

Advertisements

How should KCl-retard Hausmann be stored and disposed of?

How to Store and Dispose of KCl-retard Hausmann

The storage and disposal instructions for KCl-retard Hausmann (Potassium Chloride slow-release tablets) are designed to preserve the product's stability and prevent accidental exposure.


Storage Requirements

The medication must be kept at room temperature, away from excess heat and moisture. To maintain its integrity, the tablets must remain in the original container and the container must be kept tightly closed.

For safety, the product must always be stored out of the sight and reach of children, with all safety caps securely locked.


Disposal Instructions

Unused or expired KCl-retard Hausmann must be disposed of according to local pharmaceutical waste regulations. The medicine should not be flushed down a toilet or poured down a drain, nor should it be thrown directly into household trash. Patients should utilize an authorized drug take-back program for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of KCl-retard Hausmann found in:

A-Z Index: